What's happening in and around the Park? Here's an update. Best New Year's Wishes from the team at the Illinois Science + Technology Park.    
ISTP Ownership Changes
A venture of Hallandale Beach, Fla.-based TopMed Realty bought the 233,588 -square-foot office building at 4901 Searle Parkway. The building, which is almost fully leased to NorthShore University HealthSystem on a long-term deal, was purchased from a venture of Skokie-based American Landmark Properties

The sale comes a month after American Landmark sold the life sciences lab portion (8025 and 8045 Lamon Ave.), the majority of the leased 22.6-acre ISTP campus to Chicago-based investor Singerman Real Estate. The portfolio is comprised of a mix of highly technical wet lab and GMP space and is home to established global life sciences brands as well as prestigious university affiliated venture backed startups.

These recent sales highlight property types for which real estate investors have clamored during the COVID-19 pandemic: high-quality life sciences research buildings and office buildings with big, single tenants with good credit and long-term leases. The former has benefited from a rush of venture capital pouring into biotech and pharmaceutical research throughout the public health crisis, while the latter has drawn buyers looking for safe places to invest amid economic uncertainty.

Noted Sam DiFrancesca and Lucas Borges of the JLL Capital Markets team....

“We were encouraged by the depth of capital with an interest in Greater Chicago and are excited to see such an established national life sciences investor as Singerman committing to the market,”

"The level of lender interest in this portfolio is further testament to Chicago’s significant growth potential within the life sciences space.”

Max Zwolan and Scott Brandwein of JLL also supported the transaction and will continue to handle the leasing for the buyers.
Vetter: Best Practices Award
Vetter has been awarded the Frost & Sullivan’s 2021 Global Customer Value Leadership Award in the aseptic fill & finish market for providing high-value to our customers.

The award, presented annually by the prestigious international growth and consulting firm focuses on both business and customer impact and takes into account the current situation as well as trends in the market.

Vetter was recognized for providing high customer value, in particular, their best practices in collaboration with global customers. The committee further acknowledged the significant role Vetter plays in the success of their clients by providing crucial support from the early development phase of drugs through regulatory approval and market supply worldwide.

Managing Director Peter Soelkner noted “We always make our best efforts to provide customers with state-of-the-art services that help them improve the quality of life for patients worldwide. Our contributions to those mutual partnerships are intended to help secure their success in the global marketplace.”
Space Now Available @ISTP
There is laboratory and office space available in 8045 Lamon.  Suites, ranging from approximately 10,000 sq. ft. to over 50,000 sq. ft., are ready now. Options appropriately address your access and security concerns.  Interested? Click here!

8045 Lamon (Research to Commercialization)
  • 4 story, 163,000 square feet
  • Gold LEED rated “green” facility
  • Conference Center and Auditorium
  • Areas for meetings, collaboration and socialization

Design your customized lab & office facilities at 8030 Lamon. (Flexible Options for Development)
  • Flexible build to suit options
  • Up to 200,000 square feet of office and development space

“The Illinois Science + Technology Park is a significant contributor to Skokie’s employment base and economic growth,” said Skokie Mayor George Van Dusen. “The park continues to grow and contribute to Skokie’s economy while also providing economic stimulus for the state and Midwest region.”
NorthShore Partners with District 219

In an effort to nurture the next generation of future healthcare providers, NorthShore’s Simbulance visited Niles West High School for a learning event with District 219 and the partnered Education to Careers Program. In this video, NorthShore goes behind the scenes as these high school students receive hands-on exposure to medical simulations.

COUR Pharmaceuticals Receives FDA Fast Track Designation for CNP-104
COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders, announced the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to the Company's investigational therapy CNP-104 for the treatment of Primary Biliary Cholangitis. CNP-104 aims to reprogram the immune system to address autoimmune causes of PBC.

Fast Track Designation is an FDA process designed to facilitate the development and review of potential therapies that seek to fill an unmet medical need. The FDA created this designation to help get new therapies to patients earlier.

"We are pleased to have received Fast Track Designation for CNP-104, which demonstrates the FDA recognizes the importance of this potential treatment for PBC and the need for improved of clinical outcomes for patients with this degenerative autoimmune disease, which currently has no treatment to stop progression of disease," said COUR CEO John Puisis."
LanzaTech Holmgren: Most Innovative CEO
The most innovative bioeconomy CEO is Jennifer Holgren, CEO of LanzaTech, the Illinois-based company that is the global leader in gas fermentation technology. The company provides novel and economic routes to ethanol, jet fuel and high-value chemicals from gas streams including industrial off-gases from steel and alloy mills; petroleum refineries, petrochemical complexes and gas processing facilities; syngas generated from any biomass resource (e.g. municipal solid waste (MSW), organic industrial waste, agricultural waste); and reformed biogas.

LanzaTech’s unique microbial gas fermentation process provides a sustainable pathway to produce platform chemicals that serve as building blocks to products that have become indispensable in our lives such as rubber, plastics, synthetic fibers and fuels. The company’s technology solutions mitigate carbon emissions from industry without adversely affecting food or land security.

LanzaTech’s technology has been demonstrated at five industrial sites with over 40,000 hours of operation using steel mill waste gases (BlueScope Steel, NZ; Shougang Steel, CN; BaoSteel, CN; China Steel, TW) and approximately 30,000 hours using syngas from industrial MSW gasification (Sekisui, JPN).

Dr. Holmgren is the author or co-author of 50 US patents and more than 30 scientific publications. In 2003, she was the first woman awarded the Malcolm E. Pruitt Award from the Council for Chemical Research (CCR). In 2010, she was the recipient of the Leadership Award from the Civil Aviation Alternative Fuels Initiative (CAAFI) for her work in establishing the technical and commercial viability of sustainable aviation biofuels.
Cour Pharma Expands at ISTP
To meet the increasing demand for medical research space in the Chicagoland area, Cour Pharmaceuticals' life science and emerging biotechnology footprint is expanding within the Illinois Science and Technology Park in Skokie, Ill. With the addition, Cour Pharmaceuticals now leases around 25,000 sq. ft. in the park.

COUR Pharmaceuticals is developing first-in-class therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. COUR's platform of immune-modifying nanoparticles treats the root cause of immune disease, unlike traditional approaches, which only minimize symptoms using toxic immune suppression.
"Continued rapid growth for high-potential life science startups are emerging in Chicago and in addition to talent, life sciences companies like COUR will continue to need access to more specialized wet and dry lab space along with capital," said COUR Pharmaceuticals CEO John Puisis.

Charles River Collaboration Report
Charles River and The Harris Poll polled 1,508 Americans to determine their perceptions of the strengths and weaknesses in our healthcare system, general knowledge of drug and vaccine development and approvals, and key areas that adults in the United States would like to see prioritized in years to come.

Collaboration is particularly important for healthcare, where at the end of the day, collaboration is not only helping to improve how patients experience and receive care, but also changing their outcomes. By bringing expertise and perspectives together across the different areas that make up healthcare, partnerships between key players such as drug companies, patient advocacy groups, hospitals, and insurance companies are helping solve healthcare’s biggest challenges. At the earliest point in healthcare, collaboration is the driving force behind novel platforms that require unique discovery and development strategies that go beyond traditional

Developing new drugs and treatments isn’t easy, and it can’t be done alone. The meaning and value of collaboration varies across stakeholders, but perspectives are all anchored in the shared vision of accelerating the development and delivery of innovative treatments to give patients access as soon as possible.
Noted Jim Foster, Chairman, President and Chief Executive Officer of Charles River Laboratories.
"The key to bringing innovative, safe, and effective medicines to patients as quickly and efficiently as possible is collaboration. For us as an industry to continue to improve the quality of people’s lives through medicine, we need to better understand where we are when it comes to collaboration and identify the areas where more work is needed. This report underscores our commitment to collaboration and provides a level of insight that will help the industry navigate how we can work together moving forward."

ISTP Hosts Holiday Gift Event
The team at ISTP with the help of the Village of Skokie hosted a holiday gift fair in the atrium of the 8045 Lamon Building

A number of representatives from local Skokie businesses provided pizza, gifts and provisions to the working business and scientists who work at the park.
8000 North: Now Open for Residential Showing
Highpoint at 8000 North in Downtown Skokie is now open for residential unit showings.

The unique juxtaposition of esteemed traditional architecture by Lucien Lagrange with contemporary natural light filled interiors that are luxuriously appointed, awarding residents at Highpoint metropolitan elegance in a convenient downtown Skokie location.

With its central downtown Skokie location, Highpoint offers residents convenience with an abundance of shopping, dining and entertainment.
Check out Skokie and ISTP
Living a CarbonSmart Life